Logging into your profile is required to purchase, complete, and print certificates for AAHFN CE Educational Courses.

Already a member? Log In
Not a member? Join Now
Create a non-member profile? Create Profile

Pharm: What about Worsening Symptoms: Role of New Drugs.

SelectCourse CourseDetails ReviewMaterials EvaluateCourse PrintCertificate


Robert DiDomenico, PharmD

Learning Outcomes:

  • Highlight the mechanism of action, pharmacokinetics, side effects, contraindications, and monitoring parameters for omecamtiv and vericiguat.
  • Examine current outcomes for omecamtiv and vericiguat regarding in the management of HFrEF
  • Delineate the role of for omecamtiv and vericiguat in the management of HFrEF

This activity is approved for 0.75 contact hour(s) of continuing education by the American Association of Nurse Practitioners®. Activity ID# 22055477. This activity was planned in accordance with AANP Accreditation Standards and Policies.